CompaniesByCap
VTGN
VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare

VistaGen Therapeutics Inc. Balance Sheet 2011–2025

Income StatementBalance SheetCash Flow
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2018Mar 2017Mar 2016Mar 2013Mar 2012Mar 2011
Assets
Total Assets84.3M123.7M21.1M74.6M108.3M5.8M11.3M3.7M989,800263,700881,500323,600
Cash & Equivalents67.1M119.2M16.6M68.1M103.1M1.4M10.4M2.9M428,500638,10081,000139,300
Liabilities
Total Liabilities14.0M9.4M9.0M9.9M16.3M11.5M4.4M3.1M4.0M13.1M13.4M18.7M
Long-Term Debt58,800
Equity
Shareholders' Equity70.4M114.3M12.1M64.7M92.0M-5.7M6.9M615,800-3.0M-12.6M-5.7M-32.9M

VistaGen Therapeutics Inc. Balance Sheet — FAQ

VistaGen Therapeutics Inc. (VTGN) balance sheet over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VTGN's balance sheet history?

The chart and table above show VistaGen Therapeutics Inc.'s balance sheet by year and by quarter, including the growth rate.